Although 3-FEA has not been formally examined on the exact same stage as standard amphetamines, it is now assumed that like other substituted amphetamines with substitutions at equivalent positions, it most certainly acts largely being a triple reuptake inhibitor and/or releaser in the monoamine neurotransmitters serotonin, dopamine, and norepineph